Risk of Nephrogenic Systemic Fibrosis in Liver Transplantation Patients

Evaluation of the incidence of nephrogenic systemic fibrosis in patients with moderate renal insufficiency administered gadobenate dimeglumine for MRI

(2009) B.J. Bryant et al.   CLINICAL RADIOLOGY

Toxicity of MRI and CT contrast agents

(2009) Kendra M Hasebroock et al.   Expert Opinion on Drug Metabolism & Toxicology

Nephrogenic systemic fibrosis in liver disease: A systematic review

(2009) Sameer M. Mazhar et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

NSF prevention in clinical practice: Summary of recommendations and guidelines in the United States, Canada, and Europe

(2009) Tim Leiner et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Risk factors for NSF: A literature review

(2009) Martin R. Prince et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Nephrogenic Systemic Fibrosis and Its Impact on Abdominal Imaging

(2009) Martin R. Prince et al.   RADIOGRAPHICS

Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An Update

(2009) Jean-Marc Idée et al.   RADIOLOGIC CLINICS OF NORTH AMERICA

Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment—Report of 33 Cases

(2009) Javier Perez-Rodriguez et al.   RADIOLOGY

Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting

(2008) Dale R. Broome   EUROPEAN JOURNAL OF RADIOLOGY

Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers

(2008) Martin R. Prince et al.   RADIOLOGY